129 related articles for article (PubMed ID: 618581)
1. Correlation of antitumor chemoimmunotherapy with serum inhibition of tumor cell destruction.
Fisher B; Hanlon J; Gebhardt M; Linta J; Saffer E
Cancer Res; 1978 Jan; 38(1):38-41. PubMed ID: 618581
[TBL] [Abstract][Full Text] [Related]
2. The effect of Corynebacterium parvum in combination with 5-fluorouracil, L-phenylalanine mustard, or methotrexate on the inhibition of tumor growth.
Fisher B; Rubin H; Saffer E; Wolmark N
Cancer Res; 1976 Aug; 36(8):2714-9. PubMed ID: 1277181
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of Corynebacterium parvum, Brucella abortus extract, Bacillus Calmette-Guérin, glucan, levamisole, and tilorone with or without cyclophosphamide on tumor growth, macrophage production, and macrophage cytotoxicity in a murine mammary tumor model.
Fisher B; Gebhardt M
Cancer Treat Rep; 1978 Nov; 62(11):1919-30. PubMed ID: 728912
[TBL] [Abstract][Full Text] [Related]
4. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. X. Effect of treatment on tumor cell kinetics in mice.
Fisher B; Gunduz N
J Natl Cancer Inst; 1979 Jun; 62(6):1545-51. PubMed ID: 286125
[No Abstract] [Full Text] [Related]
5. Corynebacterium parvum and cyclophosphamide as combination treatment for a murine mammary adenocarcinoma.
Purnell DM; Bartlett GL; Kreider JW; Biro TG
Cancer Res; 1977 Apr; 37(4):1137-40. PubMed ID: 844041
[TBL] [Abstract][Full Text] [Related]
6. Comparative antitumor effects of Corynebacterium parvum, Bordetella pertussis, Bacillus Calmette-Guérin, and levamisole alone or in combination with cyclophosphamide in the CaD2 murine mammary adenocarcinoma system.
Purnell DM; Bartlett GL; Kreider JW; Biro TG; Kontra J
Cancer Res; 1979 Dec; 39(12):4838-42. PubMed ID: 498111
[TBL] [Abstract][Full Text] [Related]
7. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. IX. Macrophage content of tumors in mice.
Gebhardt MC; Fisher B
J Natl Cancer Inst; 1979 Apr; 62(4):1035-41. PubMed ID: 285276
[No Abstract] [Full Text] [Related]
8. Comparison of the inhibition of tumor growth following local or systemic administration of Corynebacterium parvum or other immunostimulating agents with or without cyclophosphamide.
Fisher B; Gebhardt M; Linta J; Saffer E
Cancer Res; 1978 Sep; 38(9):2679-87. PubMed ID: 679170
[No Abstract] [Full Text] [Related]
9. Active experimental inhibition of cancer by corynebacterium parvum.
Wrba H; Dutter A
Osterr Z Onkol; 1977 Oct; 4(2-3):60-1. PubMed ID: 579449
[TBL] [Abstract][Full Text] [Related]
10. Effect of Corynebacterium parvum on cytotoxicity of regional and nonregional lymph node cells from animals with tumors present or removed.
Fisher B; Wolmark N; Coyle J
J Natl Cancer Inst; 1974 Dec; 53(6):1793-801. PubMed ID: 4471644
[No Abstract] [Full Text] [Related]
11. Correlation of antitumor chemoimmunotherapy with bone marrow macrophage precursor cell stimulation and macrophage cytotoxicity.
Fisher B; Wolmark N
Cancer Res; 1976 Jul; 36(7 PT 1):2241-7. PubMed ID: 1277129
[TBL] [Abstract][Full Text] [Related]
12. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. III. Effect of C. parvum on cyclophosphamide metabolism.
Fisher B; Wolmark N; Rubin H
J Natl Cancer Inst; 1976 Jul; 57(1):225-6. PubMed ID: 1003505
[TBL] [Abstract][Full Text] [Related]
13. Destruction of regional lymph node metastases of rat mammary adenocarcinoma 13762A by treatment with Corynebacterium parvum.
Kreider JW; Bartlett GL; Purnell DM; Webb S
Cancer Res; 1978 Dec; 38(12):4522-6. PubMed ID: 719637
[TBL] [Abstract][Full Text] [Related]
14. [Antitumor effect of Corynebacterium parvum].
Mazurek C; Chalvet H; Biozzi G; Stiffel C
Ann Immunol (Paris); 1977; 128(1-2):161-3. PubMed ID: 576780
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of prolonged Corynebacterium parvum and cyclophosphamide administration on the growth of established tumors.
Fisher B; Wolmark N; Saffer E; Fisher ER
Cancer; 1975 Jan; 35(1):134-43. PubMed ID: 1109767
[TBL] [Abstract][Full Text] [Related]
16. Effects of dose and schedule of immune stimulant on efficacy of combination Corynebacterium parvum-cyclophosphamide treatment for a murine mammary adenocarcinoma.
Purnell DM; Bartlett GL; Kreider JW
Cancer Res; 1979 Jan; 39(1):1-5. PubMed ID: 761179
[TBL] [Abstract][Full Text] [Related]
17. The distribution and persistence in vivo of Corynebacterium parvum in relation to its antitumor activity.
Scott MT; Milas L
Cancer Res; 1977 Jun; 37(6):1673-9. PubMed ID: 870181
[TBL] [Abstract][Full Text] [Related]
18. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide--VIII.
Fisher B; Gebhardt MC; Saffer EA
Int J Radiat Oncol Biol Phys; 1978; 4(11-12):975-82. PubMed ID: 721660
[No Abstract] [Full Text] [Related]
19. Requirements for successful immunotherapy and chemoimmunotherapy of a murine model of ovarian cancer.
Vanhaelen CP; Fisher RI
Cancer Res; 1981 Mar; 41(3):980-3. PubMed ID: 7193085
[TBL] [Abstract][Full Text] [Related]
20. [Effect of the age of the mouse on the action of Corynebacterium parvum in inhibiting the growth of 2 syngenetic tumors].
Mazureka C; Stiffel C; Chalvet H; Biozzi G
C R Seances Acad Sci III; 1981 Oct; 293(4):225-8. PubMed ID: 6794870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]